Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity
Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity
BOONTON, N.J. , Jan. 11, 2012 /PRNewswire/ — Unigene Laboratories, Inc. (OTCBB: UGNE.OB – News), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that …